Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

OssDsign: Soft sales development continues - ABG

OSSDThird party research03.11.2026 klo 10.02

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* 42% beat (less negative) on adj EBIT but miss on sales
* -20% organic growth (ABGSCe -18%)
* No change in outlook


Q3 results

OssDsign reported a mixed set of numbers in Q3 with 3% lower sales, gross margin in line, but good cost control on opex resulting in a 40% beat on EBIT (less negative). Q3 sales came in at SEK 35.7m (-3% vs ABGSCe SEK 36.7m, no consensus) and adj. EBIT of SEK -6.6m, +42% vs ABGSCe of -11.4m. Organic sales growth in Q3 amounted to -20% (ABGSCe -18%). The beat on adj. EBIT is attributable to lower opex in Q3, and mainly driven by seasonal factors according to management. Q3 gross margin was 93.2% vs ABGSCe 93.0%). Even tough total opex came in some 12% below (better) than expected, we are a bit concerned to see that the 'sales and commission and fees' as percentage of sales jumped up to 49.9% in Q3 (ABGSCe 45%). Cash flow generation was better than expected, i.e. less negative, with OCF of SEK -5.3m vs. ABGSCe SEK -12.1m.


Estimates

Company is not providing any outlook for 2026 or changing its mid-term financial targets of reaching sales of SEK >400m by 2028 and to become cash flow and EBIT positive in the second half of its 'Strategy Period' (2025-2028). Based on the deviation on adj. EBIT in Q3, we expect FY'26e EBIT to be revised up by 5-7%.


Share price view

Management talk about being focused on levers that support a return to growth, but after several quarters in a row with declining sales, and no clear sign of improvements we expect investors to remain cautious until a turnaround in the sales trajectory becomes visible. The stock has traded up 4-5% into Q3 (-5d), but is down 69% YTD. We expect to see a negative share price (low single digit) reaction today on the soft sales development.